An order restricted multi‐arm multi‐stage clinical trial design
Open Access
- 19 January 2022
- journal article
- research article
- Published by Wiley in Statistics in Medicine
- Vol. 41 (9) , 1613-1626
Abstract
One family of designs that can noticeably improve efficiency in later stages of drug development are multi-arm multi-stage (MAMS) designs. They allow several arms to be studied concurrently and gain efficiency by dropping poorly performing treatment arms during the trial as well as by allowing to stop early for benefit. Conventional MAMS designs were developed for the setting, in which treatment arms are independent and hence can be inefficient when an order in the effects of the arms can be assumed (eg, when considering different treatment durations or different doses). In this work, we extend the MAMS framework to incorporate the order of treatment effects when no parametric dose-response or duration-response model is assumed. The design can identify all promising treatments with high probability. We show that the design provides strong control of the family-wise error rate and illustrate the design in a study of symptomatic asthma. Via simulations we show that the inclusion of the ordering information leads to better decision-making compared to a fixed sample and a MAMS design. Specifically, in the considered settings, reductions in sample size of around 15% were achieved in comparison to a conventional MAMS design.Keywords
Funding Information
- National Institute for Health Research (NIHR‐SRF‐2015‐08‐001, NIHR300576)
- NIHR Cambridge Biomedical Research Centre (BRC‐1215‐20014)
- Medical Research Council (MC_UU_00002/14)
This publication has 22 references indexed in Scilit:
- EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infectionJournal of Hepatology, 2012
- A generalized Dunnett test for multi-arm multi-stage clinical studies with treatment selectionBiometrika, 2012
- Testing a Primary and a Secondary Endpoint in a Group Sequential DesignBiometrics, 2010
- Hierarchical testing of multiple endpoints in group‐sequential trialsStatistics in Medicine, 2009
- Gatekeeping procedures with clinical trial applicationsPharmaceutical Statistics, 2007
- Challenges in tuberculosis drug research and developmentNature Medicine, 2007
- Sequential designs for phase III clinical trials incorporating treatment selectionStatistics in Medicine, 2003
- The Design and Analysis of Sequential Clinical Trials.1997
- Group sequential methods in the design and analysis of clinical trialsBiometrika, 1977
- A Multiple Comparison Procedure for Comparing Several Treatments with a ControlJournal of the American Statistical Association, 1955